Free Trial
LON:IMM

ImmuPharma (IMM) Share Price, News & Analysis

ImmuPharma logo
GBX 2.06 +0.19 (+9.87%)
As of 12:02 PM Eastern

About ImmuPharma Stock (LON:IMM)

Key Stats

Today's Range
1.80
2.08
50-Day Range
1.95
3.70
52-Week Range
0.85
7.40
Volume
1.30 million shs
Average Volume
6.67 million shs
Market Capitalization
£8.76 million
P/E Ratio
N/A
Dividend Yield
0.77%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IMM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ImmuPharma and its competitors with MarketBeat's FREE daily newsletter.

IMM Stock News Headlines

Critical AI announcement set to ignite AI 2.0
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
ImmuPharma PLC (25I.MU)
ImmuPharma Targets Global Partnerships at Key Biotech Events
See More Headlines

IMM Stock Analysis - Frequently Asked Questions

ImmuPharma's stock was trading at GBX 1.18 at the start of the year. Since then, IMM shares have increased by 74.9% and is now trading at GBX 2.06.

ImmuPharma plc (LON:IMM) issued its quarterly earnings data on Monday, May, 19th. The company reported ($0.60) earnings per share for the quarter. ImmuPharma had a net margin of 3,519.56% and a negative trailing twelve-month return on equity of 131.41%.

Shares of IMM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that ImmuPharma investors own include Castleton Technology (CTP), 4D pharma (DDDD), Motif Bio (MTFB), Thor Energy (THR), Aminex (AEX) and GSK (GSK).

Company Calendar

Last Earnings
5/19/2025
Today
7/16/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:IMM
CIK
N/A
Fax
N/A
Employees
13
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.58)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£2.51 million
Net Margins
3,519.56%
Pretax Margin
N/A
Return on Equity
-131.41%
Return on Assets
-43.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.60
Quick Ratio
1.03

Sales & Book Value

Annual Sales
-£71.31 thousand
Price / Sales
-122.80
Cash Flow
GBX 0.10 per share
Price / Cash Flow
20.50
Book Value
GBX 0.65 per share
Price / Book
3.19

Miscellaneous

Outstanding Shares
425,094,500
Free Float
N/A
Market Cap
£8.76 million
Optionable
Not Optionable
Beta
1.53
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (LON:IMM) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners